1. Almén T (1989) Relations between chemcial structure, animal toxicity and clinical adverse effects of contrast media. In: Enge I, Edgren J (ed) Patient safety and adverse events in contrast medium examinations. Excerpta Medica International Congress Series 816. Amsterdam: Elsevier Science Publishers, pp 25–45
2. Heglund IF, Blazak W, Michelet AA, Furuhama K, Holtz E (1995) Pre clinical pharmacokinetics and general toxicology of iodixanol. Acta Radiol (in press)
3. Speck U (1995) Pre clinical findings with iotrolan: a short review. Eur Radiol 5: s8-sl3
4. Hagen B, Wenzel-Hora BI (1989) Initial experiences with a non-ionic, dimeric contrast medium (lotrolan) in direct and indirect arteriography: a randomised, intra-individual double blind study in 60 patients. In: Taenzer V, Wende S (ed) Recent developments in non-ionic contrast media. Thieme Medical Publishers, Inc. pp 54–60
5. Grynne BH, Bolstad B, Borch KW Nossen JØ (1995) Main results from the first comparative clinical studies on VISIPAQUE®. Acta Radiol (in press)